Red Cell Partners

Founded in 2020, Red Cell Partners is an investment firm based in Washington D.C. It uniquely operates at the intersection of investing and national security, focusing on technology companies transforming defense and healthcare sectors.

George Barnes

President, Cyber Practice

Wes Bush

Director

Kevin Keaton

Founding Partner and CTO

John Tenet

Partner

13 past transactions

Hunted Labs

Pre Seed Round in 2025
Hunted Labs is a cybersecurity company specializing in software supply chain security. It equips clients, including the U.S. Department of Defense, Intelligence Community, and Fortune 500 companies, with tools to monitor, understand, and manage risks in their software development processes. The company offers services such as software supply chain security, cyber risk management, and developer workshops to help identify and mitigate potential threats.

Claros

Seed Round in 2025
Claros is a power management platform provider that utilizes cutting-edge hardware and software to enhance energy distribution and usage at data centers, thereby boosting compute performance and maximizing efficiency.

Andesite AI

Seed Round in 2025
Andesite AI specializes in enhancing the capabilities and efficiencies of cyber defense teams. It develops an AI-driven security analytics platform that enables analysts to swiftly identify threats, prioritize resources, and respond effectively, thereby improving overall security posture and reducing costs.

DEFCON AI

Seed Round in 2024
DEFCON AI is a transportation, logistics, supply chain, and storage company that develops AI-driven software to model, simulate, and analyze complex mobility and logistics scenarios, enabling organizations to optimize transportation planning, warehouse management, and overall supply chain decision-making.

Envisagenics

Series B in 2024
Envisagenics is a Huntington, New York-based company that develops a predictive analytics and bioinformatics platform to accelerate RNA therapeutics discovery. The cloud-based SpliceCore platform analyzes RNA sequencing data with artificial intelligence to identify splicing errors linked to disease, predict drug targets, and guide the design of RNA-based therapies. By translating transcriptomic insights into actionable targets, Envisagenics aims to reduce the time, cost, and risk of pharmaceutical development and to support partnerships with biopharma organizations. The firm focuses on uncovering RNA splicing alterations and translating them into therapeutic candidates, enabling researchers to validate targets and biomarkers more efficiently. The company originated as a spinout from Cold Spring Harbor Laboratory and emphasizes the use of AI and machine learning to simplify complex biomedical data for therapeutic discovery.

Andesite AI

Series A in 2024
Andesite AI specializes in enhancing the capabilities and efficiencies of cyber defense teams. It develops an AI-driven security analytics platform that enables analysts to swiftly identify threats, prioritize resources, and respond effectively, thereby improving overall security posture and reducing costs.

Eyris

Pre Seed Round in 2024
Eyris is a technology company that develops blockchain-based security solutions for businesses and organizations. Its core product is a web3-based communication and infrastructure platform designed to enhance cybersecurity and data protection. This platform offers robust data security, reducing the attack surface significantly, ensuring data immutability, and providing advanced identity and access management. By leveraging blockchain technology, Eyris enables clients to securely share data with the right individuals at the right time, even at scale.

Savoy Life

Pre Seed Round in 2023
Savoy Life operates a virtual healthcare platform that connects long-term care facilities with high-quality, coordinated medical services. It employs artificial intelligence to enhance healthcare delivery, potentially improving occupancy rates and residents' lengths of stay.

TARA Mind

Pre Seed Round in 2023
TARA Mind is a company dedicated to improving mental health outcomes by closing gaps in therapeutic accessibility and affordability for high-risk individuals. It offers employers a supplemental benefit that provides safe, affordable access to life-changing mental health therapies, focusing on treatment-resistant depression.

Epirus

Series C in 2022
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Envisagenics

Series A in 2021
Envisagenics is a Huntington, New York-based company that develops a predictive analytics and bioinformatics platform to accelerate RNA therapeutics discovery. The cloud-based SpliceCore platform analyzes RNA sequencing data with artificial intelligence to identify splicing errors linked to disease, predict drug targets, and guide the design of RNA-based therapies. By translating transcriptomic insights into actionable targets, Envisagenics aims to reduce the time, cost, and risk of pharmaceutical development and to support partnerships with biopharma organizations. The firm focuses on uncovering RNA splicing alterations and translating them into therapeutic candidates, enabling researchers to validate targets and biomarkers more efficiently. The company originated as a spinout from Cold Spring Harbor Laboratory and emphasizes the use of AI and machine learning to simplify complex biomedical data for therapeutic discovery.

Paravision

Venture Round in 2021
Founded in 2013 and based in San Francisco, Paravision specializes in developing advanced face recognition software. Trusted globally by security device manufacturers, solution providers, systems integrators, and financial services firms, their industry-leading Vision AI software delivers frictionless experiences and comprehensive safety through modular, scalable toolsets.

RED 6

Venture Round in 2021
RED 6 INC. is a company that specializes in outdoor augmented reality solutions specifically designed for air combat training. Founded in 2017 and based in Santa Monica, California, RED 6 has developed the Airborne Tactical Augmented Reality System (ATARS), which allows pilots and ground operators to visualize synthetic threats in real-time during high-speed outdoor environments. This innovative platform integrates augmented reality technology into military training, enabling real pilots in actual aircraft to engage with computer-generated enemies effectively. By utilizing an augmented reality visor, an AI-driven multiplayer network, and biometric feedback loops, RED 6 enhances training experiences, thereby improving readiness and operational capabilities for military applications. The company's technology is not only pivotal for defense but also has potential applications across various industries, including entertainment, sports, and medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.